Covance
Covance officials announce the latest developments
Published in Lab Law Weekly, May 18th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Covance.
Report 1: Covance Inc. (CVD) reported earnings for its fourth quarter ended December 31, 2006 of $0.59 per diluted share.
For the full year, EPS was $2.24, including a $0.04 per share gain from the favorable resolution of several income tax matters during the third quarter. Excluding the income tax gain, earnings were $2.20 per share, representing year-over-year EPS growth of 25.1%, with both periods including stock-based compensation expense and excluding the $0.07 per...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2007-05-18)
More Articles from Lab Law Weekly
- AARP
AARP Launches Statewide Campaign for Health Care Reform - AARP Illinois
AARP Illinois Joins Governor in Fight for Health Care Reform - Addiction Medicine
Cytos Biotechnology enters exclusive license agreement with Novartis to develop, manufacture and commercialize novel vaccine for treatment of nicotine addiction - Advanced Medical Solutions Group
Proposal for the reduction of the Company's share capital by the cancellation of its Deferred Shares of 5p each and the cancellation of its share premium account - Aging
Women Assuming Primary Caregiving Role as Society Ages - Alexza Pharmaceuticals, Inc.
Alexza Pharmaceuticals Announces Exercise of Over-Allotment Option - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
